Guolian Lifesciences (601456.SH) announces a forecasted increase, expecting the net profit attributable to the parent company in the first half of the year to be approximately 1.129 billion yuan, a year-on-year growth of around 1183%.

Zhitong Finance App News, Guolian Minsheng (601456.SH) announced that the company is expected to achieve a net profit attributable to the owners of the parent company of RMB 1.129 billion in the first half of 2025, compared with the same period of the previous year (statutory disclosure data), an increase of RMB 1.041 billion, an increase of approximately 1183% year-on-year.